Every Form 4 that Bath & Body Works Inc (BBWI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow BBWI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BBWI filings page.
Aber Ann reported acquisition or exercise transactions in this Form 4 filing.
Bath & Body Works, Inc. reported that Chief Legal Officer and Corporate Secretary Ann Aber received a new hire grant of 12,940 shares of common stock in the form of restricted stock units. The award vests 30% on the first and second anniversaries of the August 10, 2026 Grant Date, and 40% on the third anniversary, and represents her reported direct holding of 12,940 shares after the grant.
Voskuil Steven E reported acquisition or exercise transactions in this Form 4 filing.
Bath & Body Works director Steven E. Voskuil received an equity grant as part of his board compensation. On June 11, 2026, he was awarded 7,970 shares of Common Stock, reported at a price of $0.00 per share, reflecting a compensation-related award rather than a market purchase. Following this grant, his direct holdings increased to 41,895 shares of Bath & Body Works common stock. A footnote describes this as an annual award of restricted stock units to independent non-employee directors, indicating it is a routine element of the company’s director compensation program.
Rajlin Juan reported acquisition or exercise transactions in this Form 4 filing.
Bath & Body Works, Inc. director Juan Rajlin reported an equity compensation grant of 7,970 shares of common stock on June 11, 2026. The award is described as an annual grant of restricted stock units to independent non-employee directors and was issued at no cash cost. Following this grant, Rajlin directly owns 24,490 shares of Bath & Body Works common stock.
Lee Danielle M. reported acquisition or exercise transactions in this Form 4 filing.
Bath & Body Works, Inc. director Danielle M. Lee reported a compensation-related equity grant. On June 11, 2026, she received 7,970 shares of common stock at $0.00 per share as an annual award of restricted stock units granted to independent non-employee directors. Following this award, her direct holdings increased to 26,181 common shares. This is not an open-market buy or sell, but part of standard director equity compensation.
Bath & Body Works, Inc. reported that director James Kevin Symancyk received an annual equity grant under the company’s director compensation program. On June 11, 2026, he was awarded 7,970 shares of common stock at a stated price of $0.00 per share, classified as a grant or award acquisition. Following this transaction, Symancyk directly holds 48,349 common shares of Bath & Body Works.
STEINOUR STEPHEN D reported acquisition or exercise transactions in this Form 4 filing.
Bath & Body Works, Inc. director Stephen D. Steinour received an annual award of restricted stock units as an independent non-employee director. The award covers 7,970 shares of common stock at no cash cost, bringing his directly held shares to 56,145.
He also reports indirect ownership of common stock through two trusts, each holding 9,900 shares, and through his spouse, who holds 12,925 shares. These indirect positions reflect reported holdings rather than new market transactions.
Hondal Francis reported acquisition or exercise transactions in this Form 4 filing.
Bath & Body Works, Inc. director Francis Hondal reported an annual equity compensation grant. On June 11, 2026, Hondal received an award of 7,970 shares of common stock at $0.00 per share, described as an annual award of restricted stock units to independent non-employee directors.
After this grant, Hondal directly owned 13,611 shares of common stock. A separate entry shows indirect ownership of 15,913 shares held through The Francis A. Hondal Living Trust. No open-market purchases or sales were reported; the filing reflects routine director compensation and existing holdings.
Bath & Body Works, Inc. director Sarah E. Nash received an annual equity award in the form of restricted stock units. On June 11, 2026, she was granted 13,284 shares of common stock at no cash cost as director compensation. Following this grant, her direct holdings increased to 298,894.77 shares of common stock, which include 88.77 shares acquired through the company’s Dividend Reinvestment Plan.
Brady Lucy reported acquisition or exercise transactions in this Form 4 filing.
Bath & Body Works, Inc. director Lucy Brady reported an equity compensation award in the form of common stock. On June 11, 2026, she received a grant of 7,970 shares of common stock at no cash cost, described as an annual award of restricted stock units to independent non-employee directors. Following this grant, her direct holdings increased to 25,451.552 shares of Bath & Body Works common stock.
Bogliolo Alessandro reported acquisition or exercise transactions in this Form 4 filing.
Bath & Body Works director Alessandro Bogliolo received an equity grant of 7,970 shares of common stock. The award was made on June 11, 2026 as an annual grant of restricted stock units to an independent non-employee director. Following this grant, Bogliolo directly holds 24,490 shares of Bath & Body Works common stock.
Javitch Tom reported acquisition or exercise transactions in this Form 4 filing.
Bath & Body Works, Inc. reported that Interim CFO Tom Javitch received a grant of 10,309 shares of common stock on June 12, 2026 as a compensation award. The restricted stock units vest 100% on the one year anniversary of June 12, 2026. Following this grant, Javitch directly holds 59,003 common shares.
Bath & Body Works, Inc. Chief Supply Chain Officer Thomas E. Mazurek reported routine equity compensation activity. On May 19, 2026, he received 6,616 shares of common stock at $0.00 per share as a grant tied to the vesting of performance stock units originally granted on May 19, 2023. On the same date, 4,127 shares at $16.11 per share were withheld to cover tax withholding obligations related to the vesting of performance and restricted stock units. Following these transactions, he directly holds 115,170.404 shares of Bath & Body Works common stock.
Bath & Body Works, Inc. CEO Daniel Heaf reported a routine tax-related share disposition. On May 16, 2026, 7,334 shares of common stock were withheld at $17.09 per share to cover tax obligations tied to vesting restricted stock units. Following this non-market transaction, he directly holds 288,249 shares of common stock.
Heaf Daniel reported acquisition or exercise transactions in this Form 4 filing.
Bath & Body Works, Inc. reported that CEO Daniel Heaf received an equity award of 212,993 shares of common stock at no purchase price as part of his compensation. These shares are in the form of restricted stock units that vest over three years: 30% on the first anniversary of the March 12, 2026 grant date, 30% on the second anniversary, and 40% on the third anniversary. Following this grant, Heaf directly holds 295,583 shares of Bath & Body Works common stock.
Bath & Body Works, Inc. Chief Supply Chain Officer Thomas E. Mazurek reported routine equity compensation activity. On March 12, 2026, he received a grant of 40,921 restricted stock units that vest 30% on the first and second anniversaries of the grant date and 40% on the third anniversary. On March 13, 2026, 6,327 shares of common stock at $19.50 per share were withheld to cover tax obligations related to RSU vesting, not sold on the open market. Following these transactions, he directly holds 112,681.404 shares of common stock, including shares acquired through the company’s dividend reinvestment plan.
Bath & Body Works, Inc. Chief Financial Officer Eva C. Boratto reported routine equity compensation changes. She received a grant of 115,815 shares of common stock as restricted stock units that vest over three years starting on March 12, 2026. In a related step, 10,782 shares were withheld to cover tax obligations upon vesting of restricted stock units. After these transactions, she directly owns 223,459 shares of common stock.
Bath & Body Works, Inc. director reports open-market share purchase. A company director filed a Form 4 disclosing the purchase of 22,500 shares of Bath & Body Works common stock on 11/24/2025 at a weighted average price of $15.58 per share. After this transaction, the reporting person beneficially owns 40,379 common shares held directly. The filing notes that the purchase price reflects a weighted average, with individual trades executed between $15.575 and $15.58 per share, and that detailed trade-level pricing information will be made available upon request.
Bath & Body Works, Inc. (BBWI) director reported buying additional company stock. On 11/24/2025, the reporting person purchased 10,000 shares of common stock at a price of $15.58 per share. After this transaction, the director beneficially owned 285,522 shares, held directly. The filing is signed by an attorney-in-fact on behalf of the reporting person.
Bath & Body Works, Inc. (BBWI) director purchased additional company stock in the open market. On 11/21/2025, the reporting person bought 20,000 shares of common stock at a price of $15.035 per share, coded as a purchase transaction ("P").
After this transaction, the director beneficially owned 33,925 shares of Bath & Body Works common stock, held directly. The filing notes that the form was submitted for a single reporting person and was signed by an attorney-in-fact on 11/24/2025.
Bath & Body Works, Inc. (BBWI) director reported an open-market stock purchase. On 11/21/2025, the director bought 6,700 shares of common stock at a price of $14.855 per share. After this transaction, the director directly owns 48,175 shares of BBWI common stock. Additional indirect holdings include 12,925 shares held by the director's spouse and 9,900 shares each held in the Patricia M. Steinour Legacy Trust dated 10/14/2016 and the Stephen D. Steinour Dynasty Trust dated 6/1/2016. No derivative securities were reported.
Bath & Body Works, Inc. (BBWI) director reports open-market stock purchase. A director acquired 3,343 shares of common stock of Bath & Body Works, Inc. on 11/21/2025 in a reported purchase transaction at a price of $14.995 per share. Following this transaction, the director directly holds 21,554 shares of BBWI common stock. This filing is a routine Form 4 disclosure of insider share ownership and recent trading activity.
Bath & Body Works, Inc. (BBWI) director reported an open-market purchase of common stock. On 11/21/2025, the reporting person bought 3,469.552 shares of Bath & Body Works common stock at a weighted average price of $14.4 per share, coded as a purchase ("P").
After this transaction, the director beneficially owns 17,481.552 shares held directly. The price represents a weighted average, with individual purchase prices ranging from $14.40 to $14.425, and detailed breakdowns are available upon request to the company, the SEC staff, or a security holder.